1Wenzel V, Linder KH. Arginine vasopressin during cardiopulmonary resuscitation: laboratory evidence, clinical experience and recommendations, and a view to the future[ J]. Crit Care Med, 2002,30(4suppl): S157 - 161.
2Fischer M, Hossmann KA. No - reflow after cardiac arrest [ J ]. Intensive Care Med, 1995,21:132 - 141.
3Callaway CW. Improving neurologic outcomes after out - of - hospital arrest[J]. Prehosp Emerg Care, 1997,1:45- 54.
4Nichol G, Detsky AS, Stiell IG, et al. Effectiveness of emergency medical services for victims of out - of - hospital cardiac arrest: a meta analysis[J]. Ann Emerg Med, 1996,27:700- 710.
5Newman DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents[ J]. Ann Emer Med, 2000,35:472 - 480.
6Manning JE, Katz LM. Cardiopulmonary and cerebral resuscitation[ J].Critical Care Clin, 2000,16(4): 659 - 679.
7Wenzel V, Linder KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs[ J]. J Am Coll Cardiol, 2000, 35(2) :527 - 533.
8Voelckel WG, Lurie KG, McKnite S, et al. Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation [ J ]. Crit Care Med, 2002, 30 ( 5 ): 957 -962.
9Prengel AW, Lindner KH, Keller A, et al. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs[J]. Stroke, 1996,27(7): 1241 - 1248.
10Nozari A, Rubertsson S, Wiklund L. Differences in the pharmacodynamics of epinephrine and vasopressin during and after experimental eardiopulmonary resuscitation [ J]. Resuscitation, 2001,49 ( 1 ): 59 - 72.
